ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
8 announcements with these filters
Bliss GVS Pharma Ltd reported the voting results of its postal ballot. Members approved the appointment of Mr. Santosh Parab as a Non-Executive and Non-Independent Director.
Bliss GVS Pharma allotted equity shares under its Employee Stock Option Scheme (ESOP). This increases the company's total paid-up share capital.
Bliss GVS Pharma allotted 55,250 equity shares under its Employee Stock Option Plan 2019 at an exercise price of Rs. 43 per share.
Anupam Rasayan India Ltd completed an open offer to acquire 26% of Bliss GVS Pharma Ltd. Only 1,669 shares were acquired for ₹4.99 Lakh.
Bliss GVS Pharma Ltd issued a Postal Ballot Notice to seek shareholder approval for the appointment of Mr. Santosh Parab as a Director.
Bliss GVS Pharma Ltd reported revenue from operations of ₹285.6 Cr (+37.6% YoY) and net profit of ₹51.4 Cr (+15.8% YoY) for Q1 FY27.
Bliss GVS Pharma Ltd has allotted 31,250 equity shares to eligible employees under its ESOP 2019 scheme. This action increases the company's total paid-up share capital.
Life Insurance Corporation of India reduced its stake in Bliss GVS Pharma Ltd by 2.15% via market sale. The institutional investor's holding decreased to 2.96%.